True or False Adverse reactions that occur in fewer than 1 in 3,000 – 5,000 patients are unlikely to be detected in Phase I – III investigational clinical trials, and may be unknown at the time a drug is approved.
TRUE
Get your own AI website up and running! Start your new business, personal, or research website with our ready to use website scripts and templates.